|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
1.000
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
1.000
|
|
|
|
kidney development
|
GO:0001822 |
213 |
1.000
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
1.000
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
1.000
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
1.000
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
1.000
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
1.000
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.999
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.999
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.999
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.999
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.999
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.999
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.999
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.999
|
Mouse |
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.999
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.998
|
Rat |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.998
|
Rat |
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.998
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.998
|
Mouse Rat |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.998
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.998
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.998
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.998
|
Rat |
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.998
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.998
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.997
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.997
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.997
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.997
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.997
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.997
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.997
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.996
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.996
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.996
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.996
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.996
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.996
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.996
|
|
|
|
metanephric glomerular endothelium development
|
GO:0072264 |
1 |
0.995
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.995
|
Rat |
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.995
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.995
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.995
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.995
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.995
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.995
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.995
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.995
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.995
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.994
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.994
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.994
|
Mouse Rat |
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.994
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.994
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.993
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.993
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.993
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.992
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.992
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.991
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.991
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.991
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.991
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
1 |
0.991
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.991
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.990
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.990
|
|
|
|
cardiac vascular smooth muscle cell development
|
GO:0060948 |
3 |
0.990
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.990
|
Mouse |
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.989
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.989
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.989
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.987
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.987
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.987
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.987
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.986
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.986
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.986
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.986
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.985
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.985
|
|
|
|
lung vasculature development
|
GO:0060426 |
7 |
0.985
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.985
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.984
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.984
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.983
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.983
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.983
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.983
|
Rat |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.983
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.983
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.981
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.981
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.981
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.981
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.980
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.980
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.980
|
|
|
|
coronary vasculature morphogenesis
|
GO:0060977 |
9 |
0.979
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.979
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
6 |
0.979
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.978
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.978
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.978
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.978
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.977
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.977
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.977
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.977
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.976
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.976
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.976
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.975
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.974
|
|
|
|
metanephric mesangial cell differentiation
|
GO:0072209 |
1 |
0.974
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.973
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.973
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.973
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.972
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.972
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.972
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.971
|
Mouse |
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.971
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.971
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.970
|
|
|
|
positive regulation of retinal ganglion cell axon guidance
|
GO:1902336 |
2 |
0.970
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.970
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.970
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.970
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.970
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.969
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.968
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.968
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.968
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.967
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.967
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.967
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.967
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.966
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.966
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.965
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.965
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.964
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.964
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.964
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.964
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.963
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.962
|
Rat |
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.962
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.962
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.962
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.961
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.959
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.958
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.958
|
Mouse Rat |
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.958
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.958
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.958
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.958
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.957
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.957
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.957
|
Mouse Rat |
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.956
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.955
|
Rat |
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.954
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.954
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.953
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.953
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.951
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.950
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.950
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.949
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.948
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.947
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.947
|
Rat |
|
|
renal system process
|
GO:0003014 |
48 |
0.946
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.946
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.945
|
Mouse Rat |
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.945
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.945
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.944
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.944
|
Mouse |
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.941
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.941
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.941
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
11 |
0.940
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.940
|
Mouse |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.940
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.939
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.938
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.936
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.935
|
|
|
|
metanephric glomerulus vasculature morphogenesis
|
GO:0072276 |
3 |
0.935
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.935
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.935
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.934
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.934
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.934
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.934
|
Rat |
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.934
|
Rat |
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.933
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.933
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.932
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.931
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.928
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.928
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.927
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.927
|
Mouse |
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.927
|
Rat |
|
|
cgmp biosynthetic process
|
GO:0006182 |
13 |
0.924
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.924
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.924
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.921
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.920
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.919
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.919
|
Mouse |
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.919
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.918
|
|
|
|
mammary gland branching involved in pregnancy
|
GO:0060745 |
6 |
0.918
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.918
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.917
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.917
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.916
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.916
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.916
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.915
|
|
|
|
positive regulation of phosphoprotein phosphatase activity
|
GO:0032516 |
1 |
0.915
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.915
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.914
|
Rat |
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.914
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.914
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.910
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.910
|
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.910
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.909
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.909
|
|
|
|
positive regulation of mitotic cell cycle embryonic
|
GO:0045977 |
2 |
0.909
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.909
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.908
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.908
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
10 |
0.907
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.907
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.907
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.906
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.906
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.904
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.903
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.903
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.902
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.902
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.902
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.902
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.901
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.901
|
Mouse |
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.901
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.900
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.900
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.897
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.897
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.897
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.896
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.894
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.894
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
15 |
0.889
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.888
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.888
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.888
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.887
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.886
|
|
|
|
chemical homeostasis within a tissue
|
GO:0048875 |
9 |
0.886
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.886
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.884
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.884
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.884
|
Mouse |
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.883
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.883
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.882
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.881
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.877
|
|
|
|
positive regulation of dephosphorylation
|
GO:0035306 |
6 |
0.877
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.877
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.877
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.876
|
|
|
|
coronary vein morphogenesis
|
GO:0003169 |
2 |
0.874
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.874
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.873
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.870
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.870
|
|
|
|
positive regulation of lymphangiogenesis
|
GO:1901492 |
3 |
0.869
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.869
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.868
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.866
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.866
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.864
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.864
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.862
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.861
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.860
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.860
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.859
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.859
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.855
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.855
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.854
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.854
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.850
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.850
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.849
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.847
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.847
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.845
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.845
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.844
|
Rat |
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.844
|
Rat |
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.844
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.843
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.843
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.840
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.839
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.839
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.838
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.837
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.837
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.837
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.835
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.833
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.833
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.828
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.828
|
Mouse |
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.827
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.826
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.826
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.825
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.825
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.825
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
9 |
0.824
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.824
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.824
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.822
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.822
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.821
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.820
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.819
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.817
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.817
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.817
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.815
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.814
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.813
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.812
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.811
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.810
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.810
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.809
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.809
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.808
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.807
|
Rat |
|
|
melanocyte adhesion
|
GO:0097326 |
1 |
0.806
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.806
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.804
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.803
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.802
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.802
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.802
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.801
|
|
|
|
regulation of glomerular filtration
|
GO:0003093 |
3 |
0.801
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.800
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.800
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.799
|
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
5 |
0.798
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.798
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.797
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.797
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.797
|
|
|
|
metanephric glomerulus vasculature development
|
GO:0072239 |
7 |
0.794
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.794
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.792
|
Rat |
|
|
heart valve development
|
GO:0003170 |
23 |
0.792
|
|
|
|
face development
|
GO:0060324 |
38 |
0.792
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.790
|
Mouse |
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.789
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.788
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.788
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.787
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.786
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.785
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.785
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.783
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.781
|
|
|
|
positive regulation of cgmp biosynthetic process
|
GO:0030828 |
6 |
0.781
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.781
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.780
|
|
|
|
mast cell differentiation
|
GO:0060374 |
5 |
0.780
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.780
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.779
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.776
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.775
|
|
|
|
glomerular endothelium development
|
GO:0072011 |
2 |
0.774
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.774
|
|
|
|
regulation of myeloid dendritic cell activation
|
GO:0030885 |
5 |
0.772
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.772
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.772
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.771
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.771
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.770
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.769
|
|
|
|
positive regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030949 |
5 |
0.769
|
|
|
|
antral ovarian follicle growth
|
GO:0001547 |
5 |
0.768
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.764
|
|
|
|
pro b cell differentiation
|
GO:0002328 |
10 |
0.763
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.763
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.762
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.760
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.758
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.757
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.756
|
|
|
|
regulation of cgmp metabolic process
|
GO:0030823 |
12 |
0.755
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.754
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.753
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.752
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.752
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling
|
GO:0060683 |
1 |
0.752
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.751
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.749
|
|
|
|
metanephric glomerulus morphogenesis
|
GO:0072275 |
3 |
0.748
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.748
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.747
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.745
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.745
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.744
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.743
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.742
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.741
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.740
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.739
|
|
|
|
positive regulation of phosphatase activity
|
GO:0010922 |
4 |
0.739
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.738
|
Mouse |
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.735
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.732
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.732
|
|
|
|
g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger
|
GO:0007199 |
1 |
0.731
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.729
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.728
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.728
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.727
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.727
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.727
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.726
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.724
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.723
|
Mouse |
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.721
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.721
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.721
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.720
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.720
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.718
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.718
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.717
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.715
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.714
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.714
|
|
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.712
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.711
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.711
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.710
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.710
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.709
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.709
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.709
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.708
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.706
|
Rat |
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.706
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.704
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.704
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.704
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.703
|
Rat |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.703
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.702
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.702
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.701
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.700
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.699
|
|
|
|
regulation of lymphangiogenesis
|
GO:1901490 |
3 |
0.698
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.695
|
|
|
|
cardioblast migration to the midline involved in heart field formation
|
GO:0060975 |
1 |
0.695
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.695
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.695
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.694
|
|
